55 results
8-K
EX-99.1
BAX
Baxter International Inc.
6 Jul 23
Regulation FD Disclosure
8:30am
and diversity led to the appointment of three new independent directors since 2022 – William (Bill) Ampofo, Brent Shafer, and Peter Wilver – as well … Committees: CHC, QCT Peter M. Wilver Former Executive VP and Chief Administrative Officer, Thermo Fisher Scientific Committees: A*, CHC Gender Diversity
8-K
EX-99.1
BAX
Baxter International Inc.
30 Sep 22
Entry into a Material Definitive Agreement
4:16pm
on refreshment and diversity led to the appointment of four new directors in 2021-22: David Wilkes, Nancy Schlichting, Brent Directors Shafer and Peter Wilver, all … Baxter’s ability to report against the Task Force on Climate-related Financial Disclosures (TCFD) framework 1 Reflects both Board ethnic/racial diversity
8-K
EX-99.1
30n xu4i9ox
28 Jul 22
Baxter Reports Second-quarter 2022 Results
7:19am
8-K
EX-99.1
qidbq
28 Apr 22
Baxter Reports First-quarter 2022 Results
7:19am
8-K
EX-99.1
8cxsxi4ehcothv3g8ttz
17 Feb 22
Baxter Reports Fourth-quarter and Full-year 2021 Results
7:18am
8-K
EX-99.1
8yujq
13 Dec 21
Creating ~$15 Billion Global Medtech Leader
4:46pm
8-K
EX-99.1
qstsm ft3
28 Oct 21
Baxter Reports Third-quarter 2021 Results
7:18am
8-K
EX-99.1
vbz59b
18 Oct 21
October 2021 Baxter International Inc. Fall Shareholder Engagement
8:35am
8-K
EX-99.1
urnf1jywkv r66k
2 Sep 21
Entry into a Material Definitive Agreement
7:10am
8-K
EX-99.1
rfsdc ggks34
29 Apr 21
Baxter Reports First-quarter 2021 Results
7:32am
8-K
EX-99.1
rg2th
16 Feb 21
Baxter Appoints DR. David Wilkes to Its Board and Albert Stroucken As Lead Independent Director
4:35pm
8-K
EX-99.1
7o1ytngm7s6863mie
4 Feb 21
Baxter Reports Fourth-quarter and Full-year 2020 Results
7:18am